PL370428A1 - Zastosowanie siarczanowanych glikozoaminoglikanówdo doprowadzania do skutecznego porodu u kobiet - Google Patents
Zastosowanie siarczanowanych glikozoaminoglikanówdo doprowadzania do skutecznego porodu u kobietInfo
- Publication number
- PL370428A1 PL370428A1 PL03370428A PL37042803A PL370428A1 PL 370428 A1 PL370428 A1 PL 370428A1 PL 03370428 A PL03370428 A PL 03370428A PL 37042803 A PL37042803 A PL 37042803A PL 370428 A1 PL370428 A1 PL 370428A1
- Authority
- PL
- Poland
- Prior art keywords
- pregnant woman
- labor
- myometrium
- cervix
- molecular weight
- Prior art date
Links
- 229920002683 Glycosaminoglycan Polymers 0.000 title 1
- 210000003679 cervix uteri Anatomy 0.000 abstract 3
- 210000000754 myometrium Anatomy 0.000 abstract 3
- 239000003055 low molecular weight heparin Substances 0.000 abstract 2
- 229940127215 low-molecular weight heparin Drugs 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 102000004411 Antithrombin III Human genes 0.000 abstract 1
- 108090000935 Antithrombin III Proteins 0.000 abstract 1
- 229960005348 antithrombin iii Drugs 0.000 abstract 1
- 238000009109 curative therapy Methods 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 230000014508 negative regulation of coagulation Effects 0.000 abstract 1
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 abstract 1
- 230000037452 priming Effects 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0200005A SE521676C2 (sv) | 2002-01-02 | 2002-01-02 | Användning av glykosaminoglykaner för prevention och behandling av värksvaghet vid fullgången graviditet |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL370428A1 true PL370428A1 (pl) | 2005-05-30 |
| PL206458B1 PL206458B1 (pl) | 2010-08-31 |
Family
ID=20286575
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL370428A PL206458B1 (pl) | 2002-01-02 | 2003-01-02 | Zastosowanie siarczanowanych glikozoaminoglikanów w położnictwie |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US7407945B2 (pl) |
| EP (1) | EP1461049B1 (pl) |
| JP (1) | JP4434741B2 (pl) |
| KR (1) | KR100958691B1 (pl) |
| CN (1) | CN100341518C (pl) |
| AT (1) | ATE395067T1 (pl) |
| AU (1) | AU2003201787B2 (pl) |
| CA (1) | CA2472093C (pl) |
| CY (1) | CY1108260T1 (pl) |
| DE (1) | DE60320931D1 (pl) |
| DK (1) | DK1461049T3 (pl) |
| ES (1) | ES2306852T3 (pl) |
| IL (2) | IL162664A0 (pl) |
| NO (1) | NO332702B1 (pl) |
| NZ (1) | NZ533856A (pl) |
| PL (1) | PL206458B1 (pl) |
| PT (1) | PT1461049E (pl) |
| SE (1) | SE521676C2 (pl) |
| SI (1) | SI1461049T1 (pl) |
| WO (1) | WO2003055499A1 (pl) |
| ZA (1) | ZA200405015B (pl) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE521676C2 (sv) | 2002-01-02 | 2003-11-25 | Dilafor Ab | Användning av glykosaminoglykaner för prevention och behandling av värksvaghet vid fullgången graviditet |
| WO2005007223A2 (en) * | 2003-07-16 | 2005-01-27 | Sasha John | Programmable medical drug delivery systems and methods for delivery of multiple fluids and concentrations |
| US9475888B2 (en) * | 2011-12-19 | 2016-10-25 | Dilafor Ab | Non anti-coagulative glycosaminoglycans comprising repeating disaccharide unit and their medical use |
| WO2013095215A1 (en) | 2011-12-19 | 2013-06-27 | Dilaforette Ab | Low anticoagulant heparins |
| JP2015514705A (ja) * | 2012-03-26 | 2015-05-21 | ディラフォール・アクチボラゲットＤｉｌａｆｏｒ Ａｂ | 分娩停止の処置のための方法 |
| CA2868444A1 (en) * | 2012-03-26 | 2013-10-03 | Dilafor Ab | Combination treatment comprising sulphated glycosaminoglycans for inducing labor |
| MY192330A (en) * | 2012-05-08 | 2022-08-17 | Dilafor Ab | Treatment of postpartum haemorrhage with chemically modified heapin or heparan sulphate and a uterotonic agent |
| AU2013296240B2 (en) | 2012-08-03 | 2018-05-17 | Lfb Usa, Inc. | The use of antithrombin in extracorporeal membrane oxygenation |
| BR112022014456A2 (pt) | 2020-02-17 | 2022-09-13 | Dilafor Ab | Tafoxiparina para o tratamento da pré-eclâmpsia |
| EP4272749A1 (en) | 2022-05-03 | 2023-11-08 | Dilafor AB | New medical use of tafoxiparin |
| CN119136815A (zh) | 2022-05-03 | 2024-12-13 | 迪乐方有限责任公司 | 他福昔肝素的新医学用途 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5223263A (en) * | 1988-07-07 | 1993-06-29 | Vical, Inc. | Liponucleotide-containing liposomes |
| EP0209924A1 (en) * | 1985-07-12 | 1987-01-28 | Akzo N.V. | New anti-trombosis agent based on glycosaminoglycan, process for its preparation, and pharmaceutical compositions |
| US4916122A (en) * | 1987-01-28 | 1990-04-10 | University Of Georgia Research Foundation, Inc. | 3'-Azido-2',3'-dideoxyuridine anti-retroviral composition |
| US5190926A (en) * | 1987-01-28 | 1993-03-02 | University Of Georgia Research Foundation, Inc. | 3'-azido-2',3'-dideoxypyrimidines and related compounds as antiviral agents |
| SE8702254D0 (sv) | 1987-05-29 | 1987-05-29 | Kabivitrum Ab | Novel heparin derivatives |
| GB8719367D0 (en) * | 1987-08-15 | 1987-09-23 | Wellcome Found | Therapeutic compounds |
| US5968914A (en) * | 1987-10-28 | 1999-10-19 | Pro-Neuron, Inc. | Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides |
| US5470838A (en) * | 1987-10-28 | 1995-11-28 | Pro-Neuron, Inc. | Method of delivering exogenous uridine or cytidine using acylated uridine or cytidine |
| US5736531A (en) * | 1987-10-28 | 1998-04-07 | Pro-Neuron, Inc. | Compositions of chemotherapeutic agent or antiviral agent with acylated pyrimidine nucleosides |
| US6020322A (en) * | 1993-11-09 | 2000-02-01 | Pro-Neuron, Inc. | Acyl deoxyribonucleoside derivatives and uses thereof |
| US5194654A (en) * | 1989-11-22 | 1993-03-16 | Vical, Inc. | Lipid derivatives of phosphonoacids for liposomal incorporation and method of use |
| US5411947A (en) * | 1989-06-28 | 1995-05-02 | Vestar, Inc. | Method of converting a drug to an orally available form by covalently bonding a lipid to the drug |
| US5543389A (en) * | 1990-11-01 | 1996-08-06 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University, A Non Profit Organization | Covalent polar lipid-peptide conjugates for use in salves |
| US5256641A (en) * | 1990-11-01 | 1993-10-26 | State Of Oregon | Covalent polar lipid-peptide conjugates for immunological targeting |
| US5543390A (en) * | 1990-11-01 | 1996-08-06 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University | Covalent microparticle-drug conjugates for biological targeting |
| US5149794A (en) * | 1990-11-01 | 1992-09-22 | State Of Oregon | Covalent lipid-drug conjugates for drug targeting |
| US5280016A (en) | 1991-03-29 | 1994-01-18 | Glycomed Incorporated | Non-anticoagulant heparin derivatives |
| US5554728A (en) * | 1991-07-23 | 1996-09-10 | Nexstar Pharmaceuticals, Inc. | Lipid conjugates of therapeutic peptides and protease inhibitors |
| SE9302135D0 (sv) * | 1993-06-18 | 1993-06-18 | Kabi Pharmacia Ab | New pharmaceutical composition |
| US5587362A (en) * | 1994-01-28 | 1996-12-24 | Univ. Of Ga Research Foundation | L-nucleosides |
| US5559101A (en) * | 1994-10-24 | 1996-09-24 | Genencor International, Inc. | L-ribofuranosyl nucleosides |
| CA2219132C (en) * | 1995-06-07 | 2007-03-06 | Emory University | Nucleosides with anti-hepatitis b virus activity |
| US6025335A (en) * | 1995-09-21 | 2000-02-15 | Lipitek International, Inc. | L-Nucleoside Dimer Compounds and therapeutic uses |
| US5767269A (en) * | 1996-10-01 | 1998-06-16 | Hamilton Civic Hospitals Research Development Inc. | Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics |
| JP4203611B2 (ja) * | 1996-10-15 | 2009-01-07 | 生化学工業株式会社 | 子宮頸管熟化剤 |
| JP4412756B2 (ja) | 1998-02-26 | 2010-02-10 | 生化学工業株式会社 | 新規多糖誘導体、その製造法及びそれを有効成分とする医薬組成物 |
| AU4716299A (en) * | 1998-06-24 | 2000-01-10 | Emory University | Use of 3'-azido-2',3'-dideoxyuridine in combination with further anti-hiv drugs for the manufacture of a medicament for the treatment of hiv |
| IL127896A0 (en) * | 1998-12-31 | 1999-10-28 | Gail Laster | A novel treatment for preeclampsia and related diseases |
| JP2000309544A (ja) * | 1999-02-25 | 2000-11-07 | Seikagaku Kogyo Co Ltd | 早産または流産防止剤および子宮頚管熟化抑制剤ならびにヒアルロニダーゼの阻害剤 |
| SE521676C2 (sv) | 2002-01-02 | 2003-11-25 | Dilafor Ab | Användning av glykosaminoglykaner för prevention och behandling av värksvaghet vid fullgången graviditet |
-
2002
- 2002-01-02 SE SE0200005A patent/SE521676C2/sv unknown
-
2003
- 2003-01-02 AU AU2003201787A patent/AU2003201787B2/en not_active Ceased
- 2003-01-02 DE DE60320931T patent/DE60320931D1/de not_active Expired - Lifetime
- 2003-01-02 EP EP03700633A patent/EP1461049B1/en not_active Expired - Lifetime
- 2003-01-02 CA CA2472093A patent/CA2472093C/en not_active Expired - Fee Related
- 2003-01-02 DK DK03700633T patent/DK1461049T3/da active
- 2003-01-02 SI SI200331314T patent/SI1461049T1/sl unknown
- 2003-01-02 PL PL370428A patent/PL206458B1/pl unknown
- 2003-01-02 JP JP2003556076A patent/JP4434741B2/ja not_active Expired - Fee Related
- 2003-01-02 KR KR1020047010488A patent/KR100958691B1/ko not_active Expired - Fee Related
- 2003-01-02 WO PCT/SE2003/000004 patent/WO2003055499A1/en not_active Ceased
- 2003-01-02 AT AT03700633T patent/ATE395067T1/de active
- 2003-01-02 IL IL16266403A patent/IL162664A0/xx unknown
- 2003-01-02 ES ES03700633T patent/ES2306852T3/es not_active Expired - Lifetime
- 2003-01-02 CN CNB038019442A patent/CN100341518C/zh not_active Expired - Fee Related
- 2003-01-02 PT PT03700633T patent/PT1461049E/pt unknown
- 2003-01-02 NZ NZ53385603A patent/NZ533856A/xx not_active IP Right Cessation
- 2003-01-02 US US10/500,284 patent/US7407945B2/en not_active Expired - Fee Related
-
2004
- 2004-06-21 IL IL162664A patent/IL162664A/en not_active IP Right Cessation
- 2004-06-24 ZA ZA2004/05015A patent/ZA200405015B/en unknown
- 2004-07-27 NO NO20043190A patent/NO332702B1/no not_active IP Right Cessation
-
2008
- 2008-07-07 US US12/168,683 patent/US8207145B2/en not_active Expired - Fee Related
- 2008-08-13 CY CY20081100861T patent/CY1108260T1/el unknown
-
2012
- 2012-05-09 US US13/467,918 patent/US8524688B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Clagett et al. | Prevention of venous thromboembolism | |
| SI1461049T1 (sl) | Uporaba sulfatiranih glikozaminoglikanov za uvedbo učinkovitega poroda pri ženskah | |
| Mismetti et al. | Meta‐analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery | |
| WO2005055944A3 (en) | Oligosaccharide compositions and use thereof in the treatment of infection | |
| Middeldorp | Heparin: from animal organ extract to designer drug | |
| EP0066908B1 (en) | New anti-thromboticum based on polysacharides, method for its preparation and pharmaceutical compositions | |
| RU2014143008A (ru) | Способ лечения остановки родов | |
| CA2519797A1 (en) | Low molecular weight hyaluronic acid for the treatment of nerve damage | |
| Tapson et al. | Management of venous thromboembolic disease: The impact of low-molecular-weight heparin | |
| Chiapuzzo et al. | The use of low molecular weight heparins for post-surgical deep vein thrombosis prevention in orthopaedic patients | |
| RU2004108122A (ru) | Сверхразветвленный амилопектин для применения в способах хирургического или терапевтического лечения млекопитающих, или в диагностических методах, особенно для применения в качестве объемного плазмозаменителя | |
| CN110381958A (zh) | 中等分子量肝素 | |
| RU2014149230A (ru) | Лечение послеродового кровотечения (прк) | |
| EP2810641B1 (en) | Topical pharmaceutical and medical device preparations containing combinations of sucralfate, hyaluronic acid, arginine and a natural moisturizing agent | |
| Vinazzer | Advantages of low molecular weight heparin over standard heparin: facts and fiction | |
| Steiner et al. | A prospective randomized trial of low molecular weight heparin-DHE and conventional heparin-DHE (with acenocoumarol) in patients undergoing gynaecological surgery | |
| Drakos et al. | Successful Administration of Low Molecular Weight Heparin in a Patient with Heparin-lnduced Thrombocytopenia and Coumarin-lnduced Skin Necrosis | |
| AU2004294730A1 (en) | Enoxaparin for the treatment of cancer | |
| Haas et al. | An objective evaluation of the clinical potential of low molecular weight heparins in the prevention of thromboembolism | |
| Doutremepuich et al. | New class of heparin derivatives with a potent antithrombotic effect and a very limited hemorrhagic activity | |
| Poseryaev et al. | METHODS OF CONSERVATIVE TREATMENT OF VENOUS TROPHIC ULCERS ON THE OUTPATIENT STAGE | |
| Hee et al. | Overview of current practice and future trends in thromboprophylaxis for general surgery | |
| 건우이 et al. | Hyaluronic Acid and Platelet-Rich Plasma Injections in Foot and Ankle Disorders | |
| WO2006029046A3 (en) | Use of leptin in wound healing | |
| Bentley et al. | Advances in the prevention of venous thromboembolic disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RECP | Rectifications of patent specification |